Immune Checkpoint Inhibitors and Venous Thromboembolism
Dec 21, 2024 | Salim Hayek, MD, FACC
Journal Scan
Does an early rise in C-reactive protein (CRP) levels during immune checkpoint inhibitor (ICI) therapy predict the risk of venous thromboembolism (VTE) in cancer patients?
Clinical Topics: Pulmonary Hypertension and Venous Thromboembolism, Vascular Medicine, Cardio-Oncology
Keywords: C-Reactive Protein, Cardio-oncology, Immune Checkpoint Inhibitors, Venous Thromboembolism